Detalhe da pesquisa
1.
Survey by the French Medicine Agency (ANSM) of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT in the biochemical recurrence of prostate cancer in case of negative or equivocal 18F-fluorocholine PET/CT: 1084 examinations.
Eur J Nucl Med Mol Imaging
; 48(9): 2935-2950, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33416958
2.
Response to the letter to the Editor by Professors Francesco Giammarile and Stefano Fanti regarding our article "Survey by the ANSM of the imaging protocol, detection rate, and safety of 68Ga-PSMA-11 PET/CT".
Eur J Nucl Med Mol Imaging
; 48(9): 2692-2695, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34056666
3.
Current evaluation of the clinical utility of Fluoromethylcholine-(18F) PET/CT in Prostate Cancer
Braz. arch. biol. technol
; 51(spe): 71-75, Dec. 2008.
Artigo
em Inglês
| LILACS | ID: lil-508857
4.
FDOPA-(18F): a PET radiopharmaceutical recently registered for diagnostic use in countries of the European Union
Braz. arch. biol. technol
; 50(spe): 77-90, Sept. 2007. ilus
Artigo
em Inglês
| LILACS | ID: lil-478768